3Walldius G,Regnstrom J, Nilsson J ,et al. The role of lipids and antioxidant factors for development of atherosclerosis. The Probucol Quantitative Regression Swedish Trial (PQRST)[J]. Am J Cardiol, 1993,71 (6) :15B-19B.
2Li-Saw-Hee FL,Blann AD,Edmunds E,et al.Effect of acute exercise on the raised plasma fibrinogen,soluble P-selectin and yon Willebrand factor levels in chronic atrial fibrillation.Clin Cardiol 2001;24(5):409-14.
3O'Connor CM,Gurbel PA,Serebruany VL.Usefulness of soluble and surfacebound P-selectin in detecting heightened platelet activity in patients with congestive heart failure.Am J Cardiol 1999;83(9):1345-9.
4MacMachon S, Peto R ,Collins R, et al. Blood pressure, stroke and coronany heart disease (Part 1): prolonged difference in blood pressure :prospective observational studies connected for the regression dilution bias[J]. Lancet, 1990,335:765 - 774.
5Ross R. Atherosclerosis an inflammatory disease[J]. N Engl J Med, 1999,340:115 - 126.
6Carios SJ, Almasyl, Manuel soria J, et al. Cenom - wide finkage analysis of Von Willebrand factor plasma levels: results from the GAIT project[J].Thromb Haemost, 2003,89(3) :468 - 474.
7Agewall S, Wikstrand J, Fage rbeng B. Prethrombin fragment 1 + 2 is a risk factor for my o cardial infarction in treated hypertensive men[J] .J Hypertens, 1998 ,16: 537 - 541.
